RHI vs VRTX · P/E 21, rev $5.38B vs P/E 30, rev $3.33B
Robert Half International Inc (RHI) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Robert Half International Inc (RHI) is a staffing & employment services company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US. It is led by Reshma Kewalramani FASN, M.D..
Latest reported RHI revenue for 2025-12-31 was $5.38B. Net income was $133.0M. RHI currently screens at market cap $4.38B and trailing P/E 21.4.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
RHI currently screens at market cap $4.38B and trailing P/E 21.4. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the RHI and VRTX stock pages for the full models.
Not investment advice.